Opposing role of tumor necrosis factor receptor 1 signaling in T cell–mediated hepatitis and bacterial infection in mice

Hepatology

Volumn 64, Issue 2, 2016, Pages 508-521

  Wroblewski, Raluca ^a   Armaka, Marietta ^b   Kondylis, Vangelis ^c   Pasparakis, Manolis ^c   Walczak, Henning ^d   Mittrücker, Hans Willi ^a   Schramm, Christoph ^a   Lohse, Ansgar W ^a   Kollias, George ^b,e   Ehlken, Hanno ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; FAS ANTIGEN; GALACTOSAMINE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BONE MARROW CELL; CELL FUNCTION; CONCANAVALIN A-INDUCED HEPATITIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HEPATITIS; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVER CELL; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SEPTIC SHOCK; T LYMPHOCYTE; TISSUE SPECIFICITY;

EID: 84978938003     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28551     Document Type: Article

References (33)

1. Guicciardi ME, Malhi H, Mott JL, Gores GJ . Apoptosis and necrosis in the liver. Compr Physiol 2013;3:977-1010.
2. Wilson NS, Dixit V, Ashkenazi A . Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol 2009;10:348-355.
3. Ehlken H, Krishna-Subramanian S, Ochoa-Callejero L, Kondylis V, Nadi NE, Straub BK, et al. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell–specific NEMO knockout. Cell Death Differ 2014;21:1721-1732.
4. Kondylis V, Polykratis A, Ehlken H, Ochoa-Callejero L, Straub BK, Krishna-Subramanian S, et al. NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis. Cancer Cell 2015;28:582-598.
5. Yamada Y, Kirillova I, Peschon JJ, Fausto N . Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997;94:1441-1446.
6. Schiwon M, Weisheit C, Franken L, Gutweiler S, Dixit A, Meyer-Schwesinger C, et al. Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium. Cell 2014;156:456-468.
7. Sabio G, Davis RJ . TNF and MAP kinase signalling pathways. Semin Immunol 2014;26:237-245.
8. Pfeffer K, Matsuyama T, Kündig TM, Wakeham A, Kishihara K, Shahinian A, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993;73:457-467.
9. Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N, et al. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. J Hepatol 2013;58:529-534.
10. Tiegs G, Hentschel J, Wendel A . A T cell–dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90:196-203.
11. Falk LA, McNally R, Perera PY, Kenny J, Vogel SN . LPS-inducible responses in severe combined immunodeficiency (SCID) mice. Innate Immunity 1995;2:273-280.
12. Küsters S, Tiegs G, Alexopoulou L, Pasparakis M, Douni E, Künstle G, et al. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol 1997;27:2870-2875.
13. Hishinuma I, Nagakawa J, Hirota K, Miyamoto K, Tsukidate K, Yamanaka T, et al. Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice. Hepatology 1990;12:1187-1191.
14. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, et al. Cutting edge: Toll-like receptor 4 (TLR4)–deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749-3752.
15. Maeda S, Chang L, Li Z-W, Luo J-L, Leffert H, Karin M . IKKbeta is required for prevention of apoptosis mediated by cell–bound but not by circulating TNFalpha. Immunity 2003;19:725-737.
16. Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, Shakhov AN, et al. Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: protective and deleterious effects. Immunity 2005;22:93-104.
17. Das M, Sabio G, Jiang F, Rincón M, Flavell RA, Davis RJ . Induction of hepatitis by JNK-mediated expression of TNF-alpha. Cell 2009;136:249-260.
18. Van Hauwermeiren F, Armaka M, Karagianni N, Kranidioti K, Vandenbroucke RE, Loges S, et al. Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium. J Clin Invest 2013;123:2590-2603.
19. Kellendonk C, Opherk C, Anlag K, Schütz G, Tronche F . Hepatocyte-specific expression of Cre recombinase. Genesis 2000;26:151-153.
20. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I . Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999;8:265-277.
21. Alva JA, Zovein AC, Monvoisin A, Murphy T, Salazar A, Harvey NL, et al. VE-cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn 2006;235:759-767.
22. Schwenk F, Baron U, Rajewsky K . A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 1995;23:5080-5081.
23. Postic C, Magnuson MA . DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 2000;26:149-150.
24. Schwabe RF, Brenner DA . Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006;290:G583-G589.
25. Heymann F, Hamesch K, Weiskirchen R, Tacke F . The concanavalin A model of acute hepatitis in mice. Lab Anim 2015;49:12-20.
26. Seino K, Kayagaki N, Takeda K, Fukao K, Okumura K, Yagita H . Contribution of Fas ligand to T cell–mediated hepatic injury in mice. Gastroenterology 1997;113:1315-1322.
27. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K . Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000;97:5498-5503.
28. Zheng S-J, Wang P, Tsabary G, Chen YH . Critical roles of TRAIL in hepatic cell death and hepatic inflammation. J Clin Invest 2004;113:58-64.
29. Kato J, Okamoto T, Motoyama H, Uchiyama R, Kirchhofer D, van Rooijen N, et al. Interferon-gamma–mediated tissue factor expression contributes to T-cell–mediated hepatitis through induction of hypercoagulation in mice. Hepatology 2013;57:362-372.
30. Bonder CS, Ajuebor MN, Zbytnuik LD, Kubes P, Swain MG . Essential role for neutrophil recruitment to the liver in concanavalin A–induced hepatitis. J Immunol 2004;172:45-53.
31. Ni H-M, Chen X, Ding W-X, Schuchmann M, Yin X-M . Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice. Am J Pathol 2008;173:962-972.
32. Watanabe Y, Morita M, Akaike T . Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 1996;24:702-710.
33. Zhou Y, Dai W, Lin C, Wang F, He L, Shen M, et al. Protective effects of necrostatin-1 against concanavalin A–induced acute hepatic injury in mice. Mediators Inflamm 2013;2013:706156.